DexCom reported Q1 momentum tied to coverage expansion, product rollout, and operational execution, with President, CEO & Director Jacob Leach highlighting “first quarter revenue growth of 15% ...

However, DexCom maintained its fiscal 2026 revenue guidance of $5.16-5.25 billion, with a midpoint of $5.205 billion falling slightly below the analyst consensus of $5.226 billion. U.S. revenue ...

In this video, learn how to enable GPT 5.5 thinking mode in ChatGPT and discover its benefits for real-world tasks through Codex. The content covers the following topics: - How to download and install ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

What’s the next CGM step change, and how is Dexcom going to deliver it? That’s one of the fundamental questions Jake Leach has been asked since stepping into the role of CEO at Dexcom. “I want to make ...

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo as ...

Continuous glucose monitoring (CGM) tracks glucose levels every 1 to 5 minutes, helping people with diabetes understand how food, sleep, and exercise affect their blood sugar without frequent ...

Shares of DexCom Inc. DXCM shed 2.11% to $59.33 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.19% to 7,412.84 and the ...

Garmin watches can display Dexcom glucose data during workouts, while future patents hint at longer-term blood sugar insights ...

The accompanying press release dated April 30, 2026 contains non-GAAP financial measures. These non-GAAP financial measures include organic revenue, non-GAAP gross profit margin, non-GAAP operating ...

The latest price target for DexCom (NASDAQ:DXCM) was reported by Citigroup on May 4, 2026. The analyst firm set a price target for $79.00 expecting DXCM to rise to within 12 months (a possible 28.46% ...